Erythropoietin is highly elevated in vitreous fluid of patients with proliferative diabetic retinopathy

Diabetes Care

Volumn 28, Issue 9, 2005, Pages 2252-2254

  Katsura, Yoshiya ^a   Okano, Tadashi ^a   Matsuno, Kazuhisa ^a   Osako, Masahiro ^a   Kure, Masahiko ^a   Watanabe, Toshiya ^a   Iwaki, Yoshiki ^a   Noritake, Masayuki ^a   Kosano, Hiroshi ^b   Nishigori, Hideo ^b   Matsuoka, Takeshi ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; ERYTHROPOIETIN; VASCULOTROPIN;

ARTICLE; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ACTIVITY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PROTEINURIA; RETINA MACULA HOLE; STATISTICAL SIGNIFICANCE; VITRECTOMY; VITREOUS BODY;

ANOXIA; DIABETIC RETINOPATHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROPOIETIN; HUMANS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 24144477577     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.28.9.2252     Document Type: Article

References (12)

1. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL: Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613, 1996
2. Silva M, Grillot D, Benito A, Richard C, Nunez G, Fernandez-Luna JL: Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88:1576-1582, 1996
3. Genc S, Koroglu TF, Genc K: Erythropoietin and the nervous system. Brain Res 1000:19-31, 2004
4. Jaquet K, Krause K, Tawakol-Khodai M, Geidel S, Kuck KH: Erythropoietin and VEGF exhibit equal angiogenic potential. Microvasc Res 64:326-333, 2002
5. Chikuma M, Masuda S, Kobayashi T, Nagao M, Sasaki R: Tissue-specific regulation of erythropoietin production in the murine kidney, brain, and uterus. Am J Physiol Endocrinol Metab 279:E1242-E1248, 2000
6. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE: HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat Med 8:718-724, 2002
7. Inomata Y, Hirata A, Takahashi E, Kawaji T, Fukushima M, Tanihara H: Elevated erythropoietin in vitreous with ischemic retinal diseases. Neuroreport 15:877-879, 2004
8. Ando F, Nagasaka T, Sasano K, Fukumoto K: Factors influencing surgical results in proliferative diabetic retinopathy. Ger J Ophthalmol 2:155-160, 1993
9. Tilbrook PA, Klinken SP: Erythropoietin and erythropoietin receptor. Growth Factors 17:25-35, 1999
10. Friedman EA, L'Esperance FA, Brown CD, Berman DH: Treating azotemia-induced anemia with erythropoietin improves diabetic eye disease. Kidney Int (Suppl.): S57-S63, 2003
11. Junk AK, Mammis A, Savitz SI, Singh M, Roth S, Malhotra S, Rosenbaum PS, Cerami A, Brines M, Rosenbaum DM: Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A 99:10659-10664, 2002
12. Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW: Neural apoptosis in the retina during experimental and human diabetes: early onset and effect of insulin. J Clin Invest 102:783-791, 1998